Impact of Ceftriaxone and/or Fluoroquinolone (FQ) Treatment on the Gut Microbiota of Hospitalized Patients.

Impact of the Choice of 3rd Generation Cephalosporins on the Emergence of Resistance in the Microbiota Intestinal.

NCT02659033 ·Status: COMPLETED ·Phase: PHASE3

Antimicrobial Combination Therapy for Treatment of Enterococcus Faecalis Bacteremia

NCT06833593 ·Status: RECRUITING

Impact of Beta-lactams on the Microbiota and Relative Fecal Abundance of Mulltidrug Resistant Bacteria

NCT03338738 ·Status: COMPLETED ·Phase: NA

Impact on the Intestinal Microbiota of Treatment With Ceftriaxone in Women's Acute Community Pyelonephritis

NCT03179384 ·Status: COMPLETED ·Phase: PHASE4

Emergence of Bacterial Resistance to Antibiotics in the Digestive Microbiota of Patients Treated With Anticancer Drugs

NCT07093593 ·Status: NOT_YET_RECRUITING ·Phase: NA

Fecal Microbiota Transplantation (FMT) to Decolonize Antibiotic - Resistant Bacteria (ARB) - New Protocol

NCT06156956 ·Status: RECRUITING ·Phase: NA

Empirical Antibiotic and Outcome in Community-onset Bacteremia

NCT03765749 ·Status: COMPLETED

Feasibility Studies to Inform Novel Proposals to Avert Community-Based Antimicrobial Resistance Spread

NCT02666274 ·Status: UNKNOWN

Impact of Prolonged Antibiotic Therapy on Commensal Microbial Community Gene Expression.

NCT05169255 ·Status: COMPLETED ·Phase: PHASE3

Clinical Metagenomic of Post-traumatic Infections

NCT05770856 ·Status: COMPLETED

FMT to Eradicate Intestinal Colonization by Carbapenem-resistant Enterobacteriaceae

NCT05791396 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

Impact of Prescription Quality, Infection Control and Antimicrobial Stewardship on Gut Microbiota Domination by Healthcare-Associated Pathogens

NCT03765528 ·Status: UNKNOWN

Selective Reporting for Antibiotic Susceptibility Testing and GPs' Prescribing of Broad-spectrum Antibiotics in Women With E. Coli UTIs

NCT06067386 ·Status: UNKNOWN ·Phase: NA

Implications of the Human Microbiota for Health and Disease

NCT04203303 ·Status: RECRUITING

Rectal Carriage of Carbapenemase Producing-Enterobacteriaceae on Admission to a French University Teaching Hospital

NCT05798351 ·Status: RECRUITING

GSK2251052 in the Treatment of Complicated Intra-abdominal Infections

NCT01381562 ·Status: TERMINATED ·Phase: PHASE2

Gut Microbiota Association With ESBL-E Colonisation and Subsequent ESBL-E Infection

NCT04131569 ·Status: UNKNOWN

Evaluation of Heterologous Fecal microbiotA Transfer in ICU Patients: a FeasibilitY and SafetY StudY

NCT03350178 ·Status: TERMINATED ·Phase: PHASE2

Study of the Ecological and Evolutionary Dynamics of Escherichia Coli in the Digestive Commensal Flora

NCT05153824 ·Status: RECRUITING

Microbial Epidemiology and Chlorhexidine Suscebtibily of Oropharyngeal and Intestinal Colonization

NCT02839980 ·Status: COMPLETED

Short vs Long of Usual Treatment for Non Complicated Enterococcal Bacteremia

NCT05394298 ·Status: UNKNOWN ·Phase: PHASE4

Study to Assess Efficacy and Safety of PF-06947386 in Japanese Adult Patients With Complicated Intra-abdominal Infection

NCT04927312 ·Status: COMPLETED ·Phase: PHASE3

Ciprofloxacin Plus Metronidazole Vs Cefixime Plus Metronidazole Therapy for the Treatment of Liver Abscess

NCT03969758 ·Status: UNKNOWN ·Phase: PHASE3

Efficacy and Pharmacokinetic/Pharmacodynamic Parameters of Cefoxitin in Women With Acute Pyelonephritis Without Severity Symptoms Due to Extended-spectrum β-lactamase Producing Escherichia Coli

NCT01820793 ·Status: TERMINATED ·Phase: NA

Prevention and Decolonization of Multidrug-resistant Bacteria With Probiotics

NCT03967301 ·Status: UNKNOWN ·Phase: NA